PneumoWave

PneumoWave is developing real-time monitoring solutions to allow patients with respiratory conditions and their doctors to track their respiratory rates and performance out of the hospital, at home, and at work. Combining proprietary sensor technology and an innovative AI-driven digital therapeutic software platform, PneumoWave's technology enables doctors to rationalize medication use, identify early signs of deterioration, reduce or shorten hospital admissions and reduce face-to-face appointments.

PneumoWave headquartered in Europe, operates in the Artificial Intelligence (AI), Machine Learning, Health Care, Medical Device, Therapeutics, Health Diagnostics, Sensor sector. The company focuses on Artificial Intelligence (AI) and has secured $686.7M in funding across 56 round(s). With a team of 11-50 employees, PneumoWave is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Series A - PneumoWave, raised $9.2M. Discover more about their projects, partnerships, and impact on our platform.